Cimoxatone

Cimoxatone is a monoamine oxidase inhibitor (MAOI) that was developed in the 1970s for the treatment of depression. It was never marketed, but has been used in scientific research.
Pharmacology[edit]
Cimoxatone acts by inhibiting the action of the enzyme monoamine oxidase, specifically MAO-A. This enzyme is responsible for breaking down monoamine neurotransmitters in the brain, including serotonin, norepinephrine, and dopamine. By inhibiting this enzyme, Cimoxatone increases the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.
History[edit]
Cimoxatone was developed in the 1970s by the pharmaceutical company Upjohn. It was one of a number of MAOIs developed during this period, as part of a search for safer and more effective treatments for depression. However, Cimoxatone was never marketed, possibly due to concerns about the safety of MAOIs.
Research[edit]
Despite never being marketed, Cimoxatone has been used in scientific research. It has been used as a tool to study the role of monoamine oxidase in the brain, and the effects of its inhibition. It has also been used in studies of depression and other psychiatric disorders.
See also[edit]
References[edit]
<references/>
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
